Product Name | MF | CAS | Details |
---|
DB1976 dihydrochloride | C20H17ClN8Se | 2369663-93-2 | Details |
CT-721 | C30H29ClN6O | 1388710-60-8 | Details |
Frakefamide | C30H34FN5O5 | 188196-22-7 | Details |
Cyclophilin inhibitor 1 | C31H39N5O7 | 1509904-96-4 | Details |
FAK inhibitor 5 | C20H21N3O2S | 1426683-30-8 | Details |
GSK1521498 free base | C24H20F2N4 | 1007573-18-3 | Details |
EGFR-IN-2 | C26H33N9O3S | 1643497-70-4 | Details |
Closthioamide | C29H38N6O2S6 | 1227367-59-0 | Details |
EMT inhibitor-2 | C24H26N2O8 | 2232228-60-1 | Details |
DC_C66 | C28H22NO2+ | 108181-00-6 | Details |
GABAB receptor antagonist 1 | C18H24O4 | 797-17-1 | Details |
GSK1521498 | C24H23F2N4O4P | 1426543-84-1 | Details |
GF 15 | C23H21ClO6 | 888042-13-5 | Details |
GlyT1 Inhibitor 1 | C22H21N5O2 | 1820934-93-7 | Details |
CK2/PIM1-IN-1 | C15H9NO4S2 | 292640-28-9 | Details |
GC 14 | C26H27NO6 | 447415-34-1 | Details |
DSP-1053 | C26H32BrNO4 | 1176326-76-3 | Details |
CRTH2-IN-1 | C21H21FN2O4S | 926661-54-3 | Details |
CXCR7 modulator 2 | C29H42N6O3 | 2227426-37-9 | Details |
EG01377 | C26H30N6O6S2 | 2227996-00-9 | Details |
FGI-106 | C28H38N6 | 501081-38-5 | Details |
GPR120 Agonist 1 | C20H12ClF6NO3S | 1628448-77-0 | Details |
Foliglurax | C23H23N3O3S | 1883329-51-8 | Details |
DYRKs-IN-1 | C30H30ClN7O4 | 1387090-01-8 | Details |
S1PR1-MO-1 | C25H29N3O3 | 1149727-61-6 | Details |
HIV-1 integrase inhibitor 7 | C30H26O16 | 204268-03-1 | Details |
H3B-6545 Hydrochloride | C30H30ClF4N5O2 | 2052132-51-9 | Details |
JAK-IN-1 | C20H24N6O2 | 1334673-53-8 | Details |
IACS-8779 | C21H25N9O10P2S2 | 2243079-26-5 | Details |
Indirubin-5-sulfonate | C16H10N2O5S | 244021-67-8 | Details |
IL-17A antagonist 3 | C33H33ClN6O4 | 2230780-65-9 | Details |
GSK3004774 | C32H40N4O3 | 2138814-32-9 | Details |
HG-12-6 | C29H27F3N6O2S | 2222354-57-4 | Details |
GYKI 52466 dihydrochloride | C17H16ClN3O2 | 2319722-40-0 | Details |
GW768505A free base | C27H19F4N5O3 | 501693-25-0 | Details |
HDAC-IN-5 | C26H24F3N5O2S | 1314890-51-1 | Details |
G6PD activator AG1 | C24H30N4S2 | 421581-52-4 | Details |
DHODH-IN-13 | C10H6F3N3O3 | 1364791-86-5 | Details |
HMG499 | C33H54O3 | 2416941-68-7 | Details |
Derazantinib Racemate | C29H29FN4O | 2309668-44-6 | Details |
HPN-01 | C19H16ClN3O3S | 928655-63-4 | Details |
COH34 analog 1 | C18H15NO3S | 314248-24-3 | Details |
Endothelial lipase inhibitor-1 | C22H22N4O4 | 1466427-02-0 | Details |
CYP17-IN-1 | C18H17FN2S | 2093317-51-0 | Details |
DDR-TRK-1 | C26H23F3N6O | 1934246-19-1 | Details |
DHODH-IN-14 | C15H7F4N3O3 | 1364791-93-4 | Details |
DHODH-IN-15 | C15H11N3O3 | 1364791-88-7 | Details |
CP-060 | C30H42N2O5S | 180090-15-7 | Details |
DHODH-IN-8 | C17H13ClN2O2 | 1148126-03-7 | Details |
Etamicastat hydrochloride | C14H16ClF2N3OS | 677773-32-9 | Details |
hDHODH-IN-5 | C21H21F3N2O2 | 2029049-77-0 | Details |
GKI-1 | C15H12ClN3 | 2444764-03-6 | Details |
DSP-0565 | C14H12FNO | 1226855-28-2 | Details |
Ciraparantag acetate | C24H52N12O4 | 1644388-83-9 | Details |
CRT0066854 hydrochloride | C24H26ClN5S | 2250019-91-9 | Details |
CBP/p300-IN-2 | C27H29F2N7O2 | 2158265-96-2 | Details |
CDK4/6-IN-3 | C25H31FN8 | 2366237-37-6 | Details |
CCR7 Ligand 1 | C22H29N5O5S | 681514-83-0 | Details |
AHR antagonist 5 | C25H25ClFN7 | 2247953-39-3 | Details |
c-Fms-IN-9 | C21H23N7O2 | 1628574-50-4 | Details |
BIIL-260 hydrochloride | C30H31ClN2O3 | 192581-24-1 | Details |
ABT-546 | C30H48N2O6 | 212481-66-8 | Details |
MC-4R Agonist 1 | C30H38ClF2N3O2 | 455957-28-5 | Details |
AhR modulator-1 | 115039-00-4 | Details |
ACHN-975 TFA | C22H24F3N3O6 | 1410809-37-8 | Details |
AMG 487 (S-enantiomer) | C32H28F3N5O4 | 473720-30-8 | Details |
BPH-652 | C16H16K3O7PS | 157124-84-0 | Details |
AM-6494 | C22H21F2N5O3S | 1874232-80-0 | Details |
BMS-654457 | C36H37N5O4 | 1004551-41-0 | Details |
Asthma relating compound 1 | C17H19N3O3S2 | 120165-51-7 | Details |
A-9758 | C25H23Cl2F3N2O3 | 2055271-22-0 | Details |
ALK-IN-5 | C24H25FN6O3 | 2351929-66-1 | Details |
AR453588 | C25H25N7O2S2 | 1065609-00-8 | Details |
AFP464 free base | C22H23F3N4O3 | 468719-52-0 | Details |
c-Kit-IN-2 | C25H29N9O2S | 2121515-37-3 | Details |
c-Met-IN-2 | C24H21FN10O | 1635406-73-3 | Details |
β3-AR agonist 1 | C22H28N4O4S | 1283125-73-4 | Details |
BMY-43748 | C20H17F3N4O3 | 132195-65-4 | Details |
BLM-IN-1 | C28H35FN4O | 2056014-40-3 | Details |
BAY-784 | C29H26ClF4N3O5S2 | 1631164-24-3 | Details |
AR-A 2 | C27H36N4O2 | 220051-79-6 | Details |
BACE1-IN-4 | C21H23F2N5O4S2 | 2361157-92-6 | Details |
BRL-42715 | C10H9N4NaO3S | 102209-75-6 | Details |
BPN-15606 | C23H23FN6O | 1914989-49-3 | Details |
A 83-01 sodium salt | C25H20N5NaS | 2828431-89-4 | Details |
Anti-parasitic agent 3 | C21H22FN5O3 | 2366983-10-8 | Details |
BRD5631 | C30H35N3O4 | 2446154-91-0 | Details |
AZ12601011 | C19H15N5 | 2748337-86-0 | Details |
5-A-RU hydrochloride | C9H17ClN4O6 | 134452-11-2 | Details |
CCR1 antagonist 6 | C21H23ClN4O3S | 2436773-01-0 | Details |
CFTR corrector 4 | C29H27F2NO7 | 1918142-34-3 | Details |
CDK4/6/1 Inhibitor | C28H30F2N6 | 2099128-41-1 | Details |
CB2 modulator 1 | C18H19F3N4O2 | 666261-80-9 | Details |
β-NF-JQ1 | C45H42ClN5O6S | 2380000-55-3 | Details |
Antimicrobial Compound 1 | C18H30BrNO2 | 15237-83-9 | Details |
Chalcone 4 hydrate | C16H15ClO4 | 1202866-96-3 | Details |
AMPK activator 1 | C32H33F3N4O3 | 1152423-98-7 | Details |
4'-Ethynyl-2'-deoxyadenosine | C12H13N5O3 | 306305-07-7 | Details |
LTD4 antagonist 1 | C31H32F3N3O5S | 136564-67-5 | Details |
Itch-Targeting Compound 1 | C25H36ClN3O3 | 793674-76-7 | Details |
Product Total: Product Page: | ||||
68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 |